NCT03174093 Mhealth Application for anTicoagulation Care in Atrial Fibrillation Status UNKNOWN Phase NA
NCT03173534 WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement Status COMPLETED Phase NA
NCT03169608 Autonomic State, Cardiovascular Control and Outcomes in Coronary Surgery Status UNKNOWN Phase N/A
NCT03164395 The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Atrial Fibrillation Status COMPLETED Phase NA
NCT03163836 Concomitant Surgical Atrial Fibrillation Ablation in Double Valve Replacement Status UNKNOWN Phase N/A
NCT03162120 Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation Status WITHDRAWN Phase PHASE2/PHASE3
NCT03148392 Assess Differences in Pain Following Cryo and Radiofrequency Atrial Fibrillation Ablation Status UNKNOWN Phase N/A
NCT03147911 Clinical and Laboratory Predictors Associated With Stroke or Systemic Embolism in Low Risk Atrial Fibrillation Patients Status COMPLETED Phase N/A
NCT03140631 Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation Status COMPLETED Phase PHASE4
NCT03130985 Tissue, Blood and Biomarkers to Predict Future Atrial Fibrillation Status COMPLETED Phase N/A
NCT03129490 The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03126214 Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing Status COMPLETED Phase PHASE4
NCT03124654 Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC) Status COMPLETED Phase N/A